MORPHINE SULFATE INJECTION, USP
MORPHINE SULFATE INJECTION, USP
Discontinued
DIN Number
02482738
Drug Class
Human
Market Date
N/A
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02482738
AIG Number0104545020
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA01 MORPHINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intravenous
,
Intramuscular
AHFS Classification28:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
MORPHINE SULFATEActive
Strength: 8 MG / 1 ML
Monograph: MORPHINE SULFATE